Dow Up 0.51% Nasdaq Up 0.24%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
405.25 Down 0.75(0.18%) Nov 21, 4:00PM EST
|After Hours : 404.49 Down 0.76 (0.19%) Nov 21, 7:55PM EST
Prev Close:406.00
Open:415.27
Bid:N/A
Ask:410.20 x 100
1y Target Est:404.15
Beta:1.6
Earnings Date:Feb 9 - Feb 13 (Est.)
Day's Range:403.29 - 416.00
52wk Range:257.69 - 419.27
Volume:890,661
Avg Vol (3m):820,822
Market Cap:40.85B
P/E (ttm):138.55
EPS (ttm):2.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 0.18%40.85B
AMGNUp 0.08%123.84B
NVSDown 0.30%229.73B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):34.43
P/S (ttm):15.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :9.97
Quarterly EPS Est (Dec-14) :2.75
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback